Status:
COMPLETED
Effect of Photobiomodulation in Patients With Temporomandibular Dysfunction Refractory to Botulinum Toxin Treatment.
Lead Sponsor:
University of Coimbra
Collaborating Sponsors:
University of Salamanca
Conditions:
Temporomandibular Joint Disorder
Eligibility:
FEMALE
18+ years
Brief Summary
The objective of this preliminary research was to identify the effect of low-level laser photobiomodulation therapy (LLLT-PBMT) in patients with myofascial temporomandibular disorders (TMDs), refracto...
Eligibility Criteria
Inclusion
- Female patients diagnosed with TMDs. Presence of unilateral or bilateral painful symptoms. Associated conditions: Bruxism, hypertrophy of the masticatory muscles, headaches
- Previous treatment with BTX:
- Minimum of 3 doses (100 IU) Applied in masticatory muscles and intracapsular area No favorable results obtained
Exclusion
- Patients without prior treatment of this type.
- Patients receiving treatment in the Pain Unit.
- Patients undergoing invasive treatments: Open surgery in the cervicofacial region or TMJ arthrocentesis.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06915064
Start Date
March 1 2024
End Date
March 1 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Maxillofacial Surgery at the University Hospital Complex of Salamanca
Salamanca, Salamanca, Spain, 37007